Literature DB >> 12584431

Homocysteine as a risk factor for cognitive impairment in stroke patients.

Perminder S Sachdev1, Michael J Valenzuela, Henry Brodaty, Xing Li Wang, Jeffrey Looi, Lisa Lorentz, Lesley Howard, Megan Jones, Alessandro S Zagami, David Gillies, David E L Wilcken.   

Abstract

BACKGROUND: Elevated total homocysteine (tHcy) levels are associated with an increased risk of cerebrovascular disease. It is uncertain whether tHcy is also an independent risk factor for cognitive impairment.
METHODS: We examined 95 stroke subjects 3 months after their strokes, and 55 healthy comparison subjects, with a detailed neuropsychological assessment, and MRI brain scans in a proportion (n = 97). Baseline measurements of tHcy, serum folate and B(12), creatinine and plasma fibrinogen levels were obtained.
RESULTS: tHcy levels were higher in the stroke subjects by a mean 34%. These levels were significantly correlated with the first factor of a principal component analysis of the neuropsychological data, after controlling for age, folate, B(12) and creatinine levels. The correlation of Hcy levels was particularly significant with frontal-executive functioning and attention. tHcy levels were significantly correlated with number of infarcts and total stroke volume in the stroke group, but not with T(2)-weighted deep white matter hyperintensity scores, after correction for age. In the control group, tHcy levels were significantly correlated with ventricle-to-brain ratios as measures of brain atrophy.
CONCLUSION: This study provides evidence that high tHcy levels are associated with cognitive impairment, in particular that of frontal-executive function. The major component of this association is accounted for by small and large strokes, but non-vascular neurotoxic effects of tHcy also appear to play a role. tHcy must receive greater attention as a risk factor for cognitive impairment. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12584431     DOI: 10.1159/000068481

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  14 in total

1.  Beneficial antioxidant properties of betaine against oxidative stress mediated by levodopa/benserazide in the brain of rats.

Authors:  Masoud Alirezaei; Zeynab Khoshdel; Omid Dezfoulian; Marzyeh Rashidipour; Vahideh Taghadosi
Journal:  J Physiol Sci       Date:  2015-02-11       Impact factor: 2.781

2.  Relation of plasma homocysteine to plasma amyloid beta levels.

Authors:  José A Luchsinger; Ming-Xin Tang; Joshua Miller; Ralph Green; Pankash D Mehta; Richard Mayeux
Journal:  Neurochem Res       Date:  2006-12-27       Impact factor: 3.996

Review 3.  White matter hyperintensities, cognitive impairment and dementia: an update.

Authors:  Niels D Prins; Philip Scheltens
Journal:  Nat Rev Neurol       Date:  2015-02-17       Impact factor: 42.937

4.  Betaine prevents ethanol-induced oxidative stress and reduces total homocysteine in the rat cerebellum.

Authors:  Masoud Alirezaei; Gholamali Jelodar; Parvin Niknam; Zeynab Ghayemi; Saeed Nazifi
Journal:  J Physiol Biochem       Date:  2011-06-23       Impact factor: 4.158

5.  Total homocysteine and cognition in a tri-ethnic cohort: the Northern Manhattan Study.

Authors:  C B Wright; H-S Lee; M C Paik; S P Stabler; R H Allen; R L Sacco
Journal:  Neurology       Date:  2004-07-27       Impact factor: 9.910

6.  The activity of erythrocyte and brain Na+/K+ and Mg2+-ATPases in rats subjected to acute homocysteine and homocysteine thiolactone administration.

Authors:  Aleksandra Rasić-Marković; Olivera Stanojlović; Dragan Hrncić; Danijela Krstić; Mirjana Colović; Veselinka Susić; Tatjana Radosavljević; Dragan Djuric
Journal:  Mol Cell Biochem       Date:  2009-02-18       Impact factor: 3.396

7.  Diagnostic criteria for vascular cognitive disorders: a VASCOG statement.

Authors:  Perminder Sachdev; Raj Kalaria; John O'Brien; Ingmar Skoog; Suvarna Alladi; Sandra E Black; Deborah Blacker; Dan G Blazer; Christopher Chen; Helena Chui; Mary Ganguli; Kurt Jellinger; Dilip V Jeste; Florence Pasquier; Jane Paulsen; Niels Prins; Kenneth Rockwood; Gustavo Roman; Philip Scheltens
Journal:  Alzheimer Dis Assoc Disord       Date:  2014 Jul-Sep       Impact factor: 2.703

8.  Age-Dependent Association Between Elevated Homocysteine and Cognitive Impairment in a Post-stroke Population: A Prospective Study.

Authors:  Shengnan Zhou; Jiahao Chen; Lin Cheng; Kaili Fan; Minjie Xu; Wenwei Ren; Yunbin Chen; Dandan Geng; Haoran Cheng; Xiaoqian Luan; Jiaying Song; Gangqiang Lin; Guiqian Huang; Jincai He
Journal:  Front Nutr       Date:  2021-06-29

9.  Cognitive impairment after cerebrovascular stroke: Relationship to vascular risk factors.

Authors:  Eman M Khedr; Sherifa A Hamed; Hala K El-Shereef; Ola A Shawky; Khalid A Mohamed; Effat M Awad; Mohamed A Ahmed; Ghaydaa A Shehata; Mahmoud A Eltahtawy
Journal:  Neuropsychiatr Dis Treat       Date:  2009-04-08       Impact factor: 2.570

10.  Betaine protects cerebellum from oxidative stress following levodopa and benserazide administration in rats.

Authors:  Masoud Alirezaei
Journal:  Iran J Basic Med Sci       Date:  2015-10       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.